URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Pradyumna Phatak

Concepts (240)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Hemochromatosis
20
1994
38
6.120
Why?
Iron Chelating Agents
7
2007
11
2.840
Why?
Iron Overload
8
2000
11
2.660
Why?
Benzoates
4
2007
16
2.450
Why?
Triazoles
4
2007
40
2.380
Why?
Histocompatibility Antigens Class I
7
1997
93
2.040
Why?
Membrane Proteins
7
1997
560
1.780
Why?
Ferritins
9
1994
52
0.920
Why?
Blood Transfusion
4
2007
171
0.920
Why?
Mass Screening
6
1994
270
0.890
Why?
Iron
7
1994
148
0.860
Why?
Drug-Induced Liver Injury
1
2011
36
0.820
Why?
Point Mutation
3
1997
178
0.790
Why?
Bone Marrow Diseases
1
2009
44
0.670
Why?
Sex Chromosome Aberrations
1
2008
8
0.650
Why?
Chromosomes, Human, X
1
2008
10
0.650
Why?
Leukemia, Myeloid, Acute
2
1999
183
0.630
Why?
Genetic Testing
1
2008
102
0.630
Why?
Thalassemia
3
1997
23
0.620
Why?
Middle Aged
24
1989
10013
0.610
Why?
Myelodysplastic Syndromes
1
2009
132
0.600
Why?
Humans
46
1988
37165
0.590
Why?
Homozygote
6
1996
95
0.580
Why?
Genotype
7
1997
473
0.570
Why?
Mutation, Missense
3
2002
89
0.570
Why?
Lung Diseases, Interstitial
1
2005
10
0.530
Why?
Actins
6
1988
214
0.520
Why?
Liver
7
1994
884
0.510
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
2005
56
0.510
Why?
Adult
23
1994
11572
0.510
Why?
Transferrin
6
1994
38
0.500
Why?
Pyrimidines
1
2005
66
0.500
Why?
Piperazines
1
2005
76
0.500
Why?
Female
23
1994
20222
0.460
Why?
HLA Antigens
3
1996
98
0.460
Why?
Anemia
2
1997
78
0.460
Why?
Male
25
1989
20139
0.410
Why?
Cost-Benefit Analysis
4
1994
215
0.410
Why?
Osteoarthritis
1
2003
152
0.400
Why?
Aged
12
1994
7392
0.400
Why?
Administration, Oral
3
2007
314
0.390
Why?
Lymphoma
2
1997
163
0.360
Why?
Antineoplastic Agents
1
2005
628
0.350
Why?
Prevalence
5
1994
582
0.340
Why?
Corynebacterium Infections
1
1998
7
0.340
Why?
Parvoviridae Infections
1
1998
12
0.340
Why?
Infectious Mononucleosis
1
1998
21
0.340
Why?
Phenotype
5
1997
756
0.330
Why?
Dose-Response Relationship, Drug
3
1996
1142
0.330
Why?
Immunoblastic Lymphadenopathy
1
1997
5
0.320
Why?
Giant Lymph Node Hyperplasia
1
1997
5
0.320
Why?
Sarcoidosis
1
1997
33
0.310
Why?
Cation Transport Proteins
2
2005
24
0.300
Why?
Anemia, Sideroblastic
1
1997
9
0.300
Why?
Primary Myelofibrosis
1
1997
9
0.300
Why?
Splenectomy
1
1997
39
0.300
Why?
Copper
1
1997
52
0.300
Why?
Burkitt Lymphoma
3
1989
53
0.290
Why?
Diagnosis, Differential
3
1997
889
0.280
Why?
Heterozygote
2
2003
127
0.280
Why?
Lymph Nodes
1
1997
215
0.270
Why?
Liver Cirrhosis
3
2002
75
0.260
Why?
Lymphocyte Activation
1
1997
414
0.250
Why?
Phlebotomy
2
2008
5
0.240
Why?
Receptors, Antigen, T-Cell
1
1994
68
0.240
Why?
Biopsy
4
1994
384
0.230
Why?
Lymphocytes
1
1994
298
0.230
Why?
Translocation, Genetic
2
1994
65
0.220
Why?
Drug Costs
2
2008
27
0.220
Why?
Economics, Pharmaceutical
2
2007
6
0.220
Why?
Amino Acid Substitution
2
2005
133
0.210
Why?
Aged, 80 and over
4
1994
2588
0.210
Why?
Deferoxamine
2
2007
17
0.200
Why?
Mandibular Nerve
1
2011
9
0.200
Why?
Cranial Nerve Diseases
1
2011
10
0.200
Why?
Tretinoin
3
1995
104
0.190
Why?
Creatinine
1
2010
131
0.190
Why?
Safety
1
2010
106
0.190
Why?
Cross-Sectional Studies
3
1998
676
0.180
Why?
Antimicrobial Cationic Peptides
1
2009
13
0.180
Why?
Antibodies, Monoclonal
1
1994
748
0.180
Why?
Medication Adherence
1
2009
22
0.170
Why?
Adolescent
8
1994
5044
0.170
Why?
International Classification of Diseases
1
2009
15
0.170
Why?
Erythrocyte Transfusion
1
2009
58
0.170
Why?
Risk Factors
2
2003
2331
0.170
Why?
von Willebrand Diseases
2
1996
23
0.170
Why?
Early Diagnosis
1
2008
29
0.170
Why?
Mutation
4
1996
1226
0.160
Why?
Chelation Therapy
1
2008
5
0.160
Why?
Treatment Outcome
4
1997
2671
0.160
Why?
Karyotyping
1
2008
112
0.160
Why?
Anemia, Sickle Cell
1
2008
48
0.160
Why?
In Situ Hybridization, Fluorescence
1
2008
114
0.150
Why?
Protein Kinase C
2
1988
259
0.150
Why?
Treatment Refusal
1
2007
43
0.150
Why?
Granulocytes
3
1995
83
0.150
Why?
Genetic Predisposition to Disease
1
2009
317
0.150
Why?
Quality of Life
2
2000
528
0.150
Why?
Randomized Controlled Trials as Topic
1
2009
415
0.140
Why?
Case-Control Studies
1
2009
624
0.140
Why?
Child
7
1994
4342
0.140
Why?
Dyspnea
1
2005
13
0.130
Why?
Primary Health Care
2
1998
518
0.130
Why?
Interleukin-8
3
1993
111
0.130
Why?
Oxygen Inhalation Therapy
1
2005
51
0.130
Why?
Radiography, Thoracic
1
2005
61
0.130
Why?
Retrospective Studies
2
2008
2302
0.130
Why?
Gene Frequency
2
1996
87
0.130
Why?
T-Lymphocytes
1
1988
564
0.120
Why?
DNA Mutational Analysis
2
1996
192
0.120
Why?
Chondrocalcinosis
1
2003
3
0.110
Why?
Australia
1
2002
28
0.110
Why?
Hand
1
2003
73
0.110
Why?
Heart Diseases
1
2002
138
0.100
Why?
Continental Population Groups
1
2002
125
0.100
Why?
Genitalia, Female
1
2000
23
0.100
Why?
N-Formylmethionine Leucyl-Phenylalanine
3
1993
28
0.100
Why?
Age Factors
2
2000
1152
0.100
Why?
Genital Diseases, Female
1
2000
34
0.100
Why?
Family Health
1
2000
93
0.090
Why?
Cohort Studies
2
1997
984
0.090
Why?
Meninges
1
1999
21
0.090
Why?
Statistics, Nonparametric
1
2000
269
0.090
Why?
Child, Preschool
3
1994
2737
0.090
Why?
Multiple Myeloma
1
1999
75
0.090
Why?
Bone Marrow Examination
1
1998
25
0.090
Why?
Meningeal Neoplasms
1
1999
51
0.090
Why?
Blood Cell Count
1
1998
45
0.080
Why?
Leukemia, Promyelocytic, Acute
2
1995
33
0.080
Why?
Feasibility Studies
1
1998
212
0.080
Why?
Heterozygote Detection
1
1997
29
0.080
Why?
Bone Marrow Cells
1
1998
222
0.080
Why?
von Willebrand Factor
1
1996
67
0.070
Why?
Brain Neoplasms
1
1999
282
0.070
Why?
Linkage Disequilibrium
1
1996
20
0.070
Why?
Multiple Endocrine Neoplasia Type 1
1
1996
5
0.070
Why?
Purpura, Thrombocytopenic
1
1996
15
0.070
Why?
Chemotaxis
1
1996
35
0.070
Why?
Anemia, Iron-Deficiency
1
1996
39
0.070
Why?
Infant
2
1994
2320
0.070
Why?
United States
4
1996
2847
0.070
Why?
Phagocytosis
1
1996
86
0.070
Why?
Spleen
1
1997
343
0.070
Why?
Granulocyte Colony-Stimulating Factor
1
1995
45
0.070
Why?
Chromosome Mapping
1
1996
233
0.070
Why?
Bloodletting
1
1994
1
0.070
Why?
Chromosomes, Human, Pair 6
1
1994
14
0.060
Why?
Dimethyl Sulfoxide
1
1995
48
0.060
Why?
Genes, Recessive
1
1994
38
0.060
Why?
Chromosomes, Human, Pair 18
1
1994
15
0.060
Why?
Chromosomes, Human, Pair 14
1
1994
17
0.060
Why?
Chromosomes, Human, Pair 19
1
1994
14
0.060
Why?
Factor VIII
1
1996
107
0.060
Why?
Chromosomes, Human, Pair 1
1
1994
26
0.060
Why?
Dexamethasone
1
1996
188
0.060
Why?
Ionomycin
1
1994
15
0.060
Why?
Algorithms
1
1998
543
0.060
Why?
Leukemia
1
1995
158
0.060
Why?
Life Expectancy
1
1994
35
0.060
Why?
Patient Selection
1
1996
223
0.060
Why?
New York
1
1998
1378
0.060
Why?
Intracellular Membranes
1
1994
76
0.060
Why?
Protein Kinase Inhibitors
1
1994
97
0.060
Why?
Calcium
3
1993
1135
0.060
Why?
Patient Compliance
2
1998
177
0.050
Why?
Predictive Value of Tests
2
1998
609
0.050
Why?
Decision Making
1
1994
227
0.050
Why?
Neutrophils
1
1993
313
0.050
Why?
Lip
1
2011
17
0.050
Why?
Chin
1
2011
12
0.050
Why?
Sensitivity and Specificity
1
1994
914
0.050
Why?
Epidemiologic Measurements
1
2008
1
0.040
Why?
Sphingosine
1
1988
20
0.040
Why?
Cysteine
1
2009
154
0.040
Why?
Tetradecanoylphorbol Acetate
1
1988
161
0.040
Why?
Cell Transformation, Neoplastic
1
1989
138
0.040
Why?
Pyridones
1
2007
11
0.040
Why?
Lymphoma, Follicular
1
1989
61
0.040
Why?
Cardiomyopathies
1
2008
80
0.040
Why?
Fatal Outcome
2
1996
109
0.040
Why?
Protein Conformation
1
1988
324
0.040
Why?
Databases, Factual
1
2008
159
0.040
Why?
beta-Thalassemia
1
2007
7
0.040
Why?
Drug Utilization Review
1
2007
8
0.040
Why?
Ethnic Groups
1
2008
160
0.040
Why?
Insurance Claim Review
1
2007
28
0.040
Why?
Cost of Illness
1
2007
79
0.040
Why?
Markov Chains
1
2007
40
0.040
Why?
Infusions, Intravenous
1
2007
143
0.040
Why?
Enzyme Activation
1
1988
611
0.040
Why?
Drug Administration Schedule
1
2007
374
0.030
Why?
Genes, Dominant
1
2005
82
0.030
Why?
Pedigree
1
2005
232
0.030
Why?
Delivery of Health Care
1
2007
157
0.030
Why?
Signal Transduction
1
1993
1629
0.030
Why?
Alanine Transaminase
1
2003
24
0.030
Why?
Liver Function Tests
1
2003
30
0.030
Why?
Aspartate Aminotransferases
1
2003
36
0.030
Why?
ROC Curve
1
2003
130
0.030
Why?
Regression Analysis
1
2003
539
0.020
Why?
Menstruation
1
2000
16
0.020
Why?
Labor, Obstetric
1
2000
32
0.020
Why?
Logistic Models
1
2003
626
0.020
Why?
Cell Differentiation
2
1995
1127
0.020
Why?
False Positive Reactions
1
1998
88
0.020
Why?
Informed Consent
1
1998
86
0.020
Why?
Education, Medical, Continuing
1
1998
70
0.020
Why?
Radiotherapy
1
1999
198
0.020
Why?
Cerebral Cortex
1
1999
257
0.020
Why?
Ristocetin
1
1996
6
0.020
Why?
Bleeding Time
1
1996
9
0.020
Why?
HL-60 Cells
1
1996
50
0.020
Why?
DNA Probes
1
1996
87
0.020
Why?
L-Selectin
1
1995
15
0.020
Why?
Biological Markers
1
1998
564
0.020
Why?
Genetic Markers
1
1996
132
0.020
Why?
Antineoplastic Combined Chemotherapy Protocols
1
1999
436
0.020
Why?
Alleles
1
1996
206
0.020
Why?
Integrins
1
1995
48
0.020
Why?
Antigens, Surface
1
1995
100
0.020
Why?
Nitroblue Tetrazolium
1
1995
4
0.020
Why?
Dimerization
1
1996
167
0.020
Why?
Immunophenotyping
1
1995
126
0.020
Why?
Cell Adhesion Molecules
1
1995
73
0.020
Why?
Cell Size
1
1995
96
0.020
Why?
Questionnaires
1
2000
1061
0.020
Why?
Pregnancy
1
2000
1941
0.020
Why?
Chemotaxis, Leukocyte
1
1995
29
0.020
Why?
Neoplasm Metastasis
1
1996
229
0.020
Why?
Oxidation-Reduction
1
1995
304
0.010
Why?
Pertussis Toxin
1
1993
53
0.010
Why?
Virulence Factors, Bordetella
1
1993
55
0.010
Why?
Polymerase Chain Reaction
1
1996
597
0.010
Why?
Bone Marrow
1
1994
292
0.010
Why?
Polymers
1
1993
84
0.010
Why?
Tumor Cells, Cultured
1
1995
886
0.010
Why?
Molecular Sequence Data
1
1996
2046
0.010
Why?
Follow-Up Studies
1
1989
1889
0.010
Why?
Time Factors
1
1989
3234
0.010
Why?

Visualizations


Phatak's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department